Efficacy, Safety and Cost Effectiveness of Four Therapeutic Agents for Treatment of Scabies

未提供0 个研究点目标入组 250 人开始时间: 2015年4月25日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•scabies; patients experiencing itching that involved at least three distinct sites on the body and had lesions that were characteristic of scabies
•history of nocturnal itching
•history of involvment of family members
•history of contact with scabies pateint
•presence of classical burrows on clinical examination
•presence of typical scabietic lesions like,papules, nodules and vesicles
•either gender
•above 5years of age
•willing to participate

•Pregnant or lactating women.
•Children < 5 years old and adult >50 years old.
•body weight less than 15 kg.
•Participants had a general condition such as abnormal liver and kidney functions, known thyroid disease, cardiac disorders, nervous system disorder, and psychiatric illnesses.
•participants with history of diabetes mellitus, hypertension, or chronic infectious diseases.
•Participants with any other associated skin disease, which could alter the picture of scabies.
•immunocompromised individuals, having scabies with atypical presentations like crusted scabies.
•Participants who had taken any antiscabetic treatment in the preceding month.

发起方

未提供